Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02499909
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
DM7![]() | 4'-DEOXY-4'-IODODOXORUBICIN | A | 1IMR | 0.7 | ![]() |
DM7![]() | 4'-DEOXY-4'-IODODOXORUBICIN | A | 1IMS | 0.7 | ![]() |
NGM![]() | NOGALAMYCIN | A,B,C,D | 258D | 0.71 | ![]() |
NGM![]() | NOGALAMYCIN | A | 282D | 0.71 | ![]() |
NGM![]() | NOGALAMYCIN | A,B | 224D | 0.71 | ![]() |
NGM![]() | NOGALAMYCIN | A,B | 245D | 0.71 | ![]() |
NGM![]() | NOGALAMYCIN | A,B | 1QCH | 0.71 | ![]() |
NGM![]() | NOGALAMYCIN | A | 1D17 | 0.71 | ![]() |
NGM![]() | NOGALAMYCIN | A,B | 1D21 | 0.71 | ![]() |
NGM![]() | NOGALAMYCIN | A,B | 182D | 0.71 | ![]() |
AP1![]() | {3-[3-(3,4-DIMETHOXY-PHENYL)-1- (1-{1-[2-(3,4,5-TRIMETHOXY-PHENYL)- BUTYRYL]-PIPERIDIN-2YL}-VINYLOXY)- PROPYL]-PHENOXY}-ACETIC ACID | A,B | 1BL4 | 0.73 | ![]() |
ERT![]() | METHYL (4R)-2-ETHYL-2,5,12-TRIHYDROXY- 7-METHOXY-6,11-DIOXO-4-{[2,3,6- TRIDEOXY-3-(DIMETHYLAMINO)-BETA- D-RIBO-HEXOPYRANOSYL]OXY}-1H,2H,3H,4H,6H,11H- TETRACENE-1-CARBOXYLATE | A,B | 1TW2 | 0.73 | ![]() |
ERT![]() | METHYL (4R)-2-ETHYL-2,5,12-TRIHYDROXY- 7-METHOXY-6,11-DIOXO-4-{[2,3,6- TRIDEOXY-3-(DIMETHYLAMINO)-BETA- D-RIBO-HEXOPYRANOSYL]OXY}-1H,2H,3H,4H,6H,11H- TETRACENE-1-CARBOXYLATE | A,B | 1TW3 | 0.73 | ![]() |
SC6![]() | N-{(1S,2R)-1-(3,5-DIFLUOROBENZYL)- 2-HYDROXY-2-[(2R,4R)-4-PHENOXYPYRROLIDIN- 2-YL]ETHYL}-3-{[(2R)-2-(METHOXYMETHYL)PYRROLIDIN- 1-YL]CARBONYL}-5-METHYLBENZAMIDE | A,B | 2QMG | 0.71 | ![]() |
DEO![]() | A,B | 1ROS | 0.75 | ![]() | |
NGP![]() | NOGALAMYCIN (PROTONATED FORM) | A | 1L0R | 0.71 | ![]() |
C39![]() | N-[(2S,4S,5S,7R)-4-AMINO-8-(BUTYLAMINO)- 5-HYDROXY-7-METHYL-2-(1-METHYLETHYL)- 8-OXOOCTYL]-2-(3-METHOXYPROPOXY)BENZAMIDE | C,O | 2V12 | 0.72 | ![]() |
C01![]() | (2S)-(4-ISOPROPYLPHENYL)[(2-METHYL- 3-OXO-5,7-DIPROPYL-2,3-DIHYDRO- 1,2-BENZISOXAZOL-6-YL)OXY]ACETATE | A | 1ZEO | 0.71 | ![]() |
MUS![]() | 4-METHYL-2-OXO-2H-CHROMEN-7-YL 5- (ACETYLAMINO)-3,5-DIDEOXY-L-ERYTHRO- NON-2-ULOPYRANOSIDONIC ACID | A | 1S0J | 0.74 | ![]() |
DBL![]() | DEGLUCOBALHIMYCIN | A,B,C,P | 1HHZ | 0.74 | ![]() |
DBL![]() | DEGLUCOBALHIMYCIN | A,B,N,P | 1HHY | 0.74 | ![]() |
BHP![]() | (S)-5-(4-BENZYLOXY-PHENYL)-4-(7- PHENYL-HEPTANOYLAMINO)-PENTANOIC ACID | A,B | 1J1A | 0.71 | ![]() |
CHR![]() | NEOCARZINOSTATIN-CHROMOPHORE | A | 1O5P | 0.74 | ![]() |
CHR![]() | NEOCARZINOSTATIN-CHROMOPHORE | A,B | 1NCO | 0.74 | ![]() |
MFN![]() | N-[4,5,7-TRICARBOXYHEPTANOYL]-L- GAMMA-GLUTAMYL-N-{2-[4-({5-[(FORMYLAMINO)METHYL]- 3-FURYL}METHOXY)PHENYL]ETHYL}-D- GLUTAMINE | A,B,C,D | 2FHK | 0.72 | ![]() |
MFN![]() | N-[4,5,7-TRICARBOXYHEPTANOYL]-L- GAMMA-GLUTAMYL-N-{2-[4-({5-[(FORMYLAMINO)METHYL]- 3-FURYL}METHOXY)PHENYL]ETHYL}-D- GLUTAMINE | A,B,C,D | 2FHJ | 0.72 | ![]() |
AI1![]() | N-BENZYL-3-(ALPHA-D-GALACTOS-1- YL)-BENZAMIDE | D,E,F,G,H,L, M,N,O,P | 1FD7 | 0.76 | ![]() |
SUW![]() | ME-A-9-N-(NAPHTHYL-2-CARBONYL)- AMINO-9-DEOXY-NEU5AC | A | 1OD7 | 0.7 | ![]() |
MAR![]() | 4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN | A | 1D36 | 0.71 | ![]() |
MAR![]() | 4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN | A | 1R68 | 0.71 | ![]() |
MAR![]() | 4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN | A | 1D35 | 0.71 | ![]() |
ECA![]() | N,N',N''-[BENZENE-1,3,5-TRIYLTRIS(METHYLENE)]TRIS(2,3- DIHYDROXYBENZAMIDE) | A,B | 2CHU | 0.72 | ![]() |
BA1![]() | BALANOL | A | 1BX6 | 0.76 | ![]() |
S2A![]() | A | 2OEY | 0.72 | ![]() | |
EB4![]() | N,N',N''-[(3S,7S,11S)-2,6,10-trioxo- 1,5,9-trioxacyclododecane-3,7,11- triyl]tris(2,3-dihydroxybenzamide) | A,B,C | 3CMP | 0.75 | ![]() |
NLX![]() | (5A,17R)-4,5-EPOXY-3,14-DIHYDROXY- 17-METHYL-6-OXO-17-(2-PROPENYL)- MORPHINANIUM | A,B,C,D,E,F, G,H,I,J,K,L | 1MX9 | 0.7 | ![]() |
CS9![]() | N'-{(1S,2R)-1-(3,5-DIFLUOROBENZYL)- 2-HYDROXY-2-[(2R,4R)-4-PHENOXYPYRROLIDIN- 2-YL]ETHYL}-5-METHYL-N,N-DIPROPYLISOPHTHALAMIDE | A,B | 2QMF | 0.7 | ![]() |
UMG![]() | METHYL-UMBELLIFERTL-N-ACETYL-CHITOTRIOSE | A | 1BB6 | 0.71 | ![]() |
L75![]() | N-[2(R)-HYDROXY-1(S)-INDANYL]-2(R)- PHENYLMETHYL-4(S)-HYDROXY-5-[4- [2-BENZOFURANYLMETHYL]-2(S)-[TERT- BUTYLAMINOCARBONYL]-PIPERAZINYL]- PENTANEAMIDE | B | 1C70 | 0.71 | ![]() |
B8L![]() | 3-[(3-SEC-BUTYL-4-HYDROXYBENZOYL)AMINO]AZEPAN- 4-YL 4-(2-HYDROXY-5-METHOXYBENZOYL)BENZOATE | A | 1REK | 0.74 | ![]() |
429![]() | 2-{4-[2-ACETYLAMINO-3-(4-CARBOXYMETHOXY- 3-HYDROXY-PHENYL)-PROPIONYLAMINO]- BUTOXY}-6-HYDROXY-BENZOIC ACID METHYL ESTER | A | 1QXK | 0.79 | ![]() |
NOD![]() | N-ETHYLHYDROXY-DOXORUBICIN | A | 385D | 0.74 | ![]() |
DM8![]() | 2'-BROMO-4'-EPIDAUNORUBICIN | A | 276D | 0.7 | ![]() |
DM8![]() | 2'-BROMO-4'-EPIDAUNORUBICIN | A | 288D | 0.7 | ![]() |
DM8![]() | 2'-BROMO-4'-EPIDAUNORUBICIN | A | 277D | 0.7 | ![]() |
DM8![]() | 2'-BROMO-4'-EPIDAUNORUBICIN | A,B | 380D | 0.7 | ![]() |
DM8![]() | 2'-BROMO-4'-EPIDAUNORUBICIN | A,B | 381D | 0.7 | ![]() |
DM8![]() | 2'-BROMO-4'-EPIDAUNORUBICIN | A | 278D | 0.7 | ![]() |
C40![]() | N-[(2R,4S,5S,7R)-4-AMINO-8-(BUTYLAMINO)- 5-HYDROXY-2,7-DIMETHYL-8-OXOOCTYL]- 2-(3-METHOXYPROPOXY)BENZAMIDE | A | 2V13 | 0.71 | ![]() |
9AR![]() | 9-HYDROXY ARISTOLOCHIC ACID | A,B | 1FV0 | 0.72 | ![]() |
L01![]() | 3-[({(1S,2R)-1-BENZYL-2-HYDROXY- 3-[(3-METHOXYBENZYL)AMINO]PROPYL}AMINO)(HYDROXY)METHYL]- N,N-DIPROPYLBENZAMIDE | A | 1W51 | 0.71 | ![]() |
NCS![]() | B | 1KVH | 0.72 | ![]() | |
NCS![]() | A | 2NEO | 0.72 | ![]() | |
NGU![]() | U-58872, HYDROXY DERIVATIVE OF NOGALAMYCIN | A,B | 1D22 | 0.71 | ![]() |
HMT![]() | (3beta)-O~3~-[(2R)-2,6-dihydroxy- 2-(2-methoxy-2-oxoethyl)-6-methylheptanoyl]cephalotaxine | 0,1,2,3,9,A, B,C,F,J,K,L, M,N,O,Q,R,S, T,U,Y,Z | 3G6E | 0.73 | ![]() |
ROM![]() | C-1027 AROMATIZED CHROMOPHORE | A | 1HZL | 0.71 | ![]() |
POD![]() | 9-HYDROXY-5-(3,4,5-TRIMETHOXYPHENYL)- 5,8,8A,9-TETRAHYDROFURO[3',4':6,7]NAPHTHO[2,3- D][1,3]DIOXOL-6(5AH)-ONE | A,B,C,D | 1SA1 | 0.74 | ![]() |
VAN![]() | VANCOMYCIN | A | 1C0R | 0.73 | ![]() |
VAN![]() | VANCOMYCIN | A,B | 1SHO | 0.73 | ![]() |
VAN![]() | VANCOMYCIN | A,B | 1PNV | 0.73 | ![]() |
VAN![]() | VANCOMYCIN | A | 1C0Q | 0.73 | ![]() |
VAN![]() | VANCOMYCIN | A | 1QD8 | 0.73 | ![]() |
VAN![]() | VANCOMYCIN | A,B,C,D,E,F | 1FVM | 0.73 | ![]() |
VAN![]() | VANCOMYCIN | A | 1AA5 | 0.73 | ![]() |
401![]() | (2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]- 4-methoxybenzyl}butanoic acid | A,B | 2ZNQ | 0.7 | ![]() |
VAG![]() | VANCOMYCIN AGLYCON | A | 1GHG | 0.73 | ![]() |
DVV![]() | DESVANCOSAMINYL VANCOMYCIN | A,B | 1PN3 | 0.74 | ![]() |
DVV![]() | DESVANCOSAMINYL VANCOMYCIN | A,B | 1RRV | 0.74 | ![]() |
NCG![]() | A | 1MP7 | 0.73 | ![]() | |
B1L![]() | 3-[(4-HYDROXYBENZOYL)AMINO]AZEPAN- 4-YL 4-HYDROXYBENZOATE | A | 1REJ | 0.72 | ![]() |
FLQ![]() | N-[6-(ACETYLAMINO)HEXYL]-3',6'- DIHYDROXY-3-OXO-3H-SPIRO[2-BENZOFURAN- 1,9'-XANTHENE]-6-CARBOXAMIDE | C | 2FDC | 0.81 | ![]() |
BNR![]() | BIS-DAUNORUBICIN | B | 1AMD | 0.73 | ![]() |
BDA![]() | 4-METHYLBENZYL-N-BIS[DAUNOMYCIN] | A | 1AL9 | 0.75 | ![]() |
BDA![]() | 4-METHYLBENZYL-N-BIS[DAUNOMYCIN] | A | 1AGL | 0.75 | ![]() |
MNG![]() | MENOGARIL | A,B | 202D | 0.71 | ![]() |
CC0![]() | (4-{2-ACETYLAMINO-2-[1-(3-CARBAMOYL- 4-CYCLOHEXYLMETHOXY-PHENYL)-ETHYLCARBAMOYL}- ETHYL}-2-PHOSPHONO-PHENOXY)-ACETIC ACID | A | 1IJR | 0.72 | ![]() |
K55![]() | (2S)-2-{4-butoxy-3-[({[2-fluoro- 4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]benzyl}butanoic acid | A,B | 2ZNP | 0.71 | ![]() |
PI8![]() | N-13-[(10S,13S)-9,12-DIOXO-10-(2- BUTYL)-2-OXA-8,11-DIAZABICYCLO [13.2.2] NONADECA- 15,17,18-TRIENE] (2R)-BENZYL-(4S)- HYDROXY-5-AMINOPENTANOIC (1R)-HYDROXY- (2S)-INDANEAMIDE | A,B | 1D4K | 0.71 | ![]() |
PCY![]() | PACTAMYCIN | A,D,H,N | 1HNX | 0.7 | ![]() |
CYF![]() | 5-[2-(2-AMINO-2-CARBAMOYL-ETHYLSULFANYL)- ACETYLAMINO]-2-(3,6-DIHYDROXY-9,9A- DIHYDRO-3H-XANTHEN-9-YL)-BENZOIC ACID | L,P | 1MPA | 0.72 | ![]() |
CYF![]() | 5-[2-(2-AMINO-2-CARBAMOYL-ETHYLSULFANYL)- ACETYLAMINO]-2-(3,6-DIHYDROXY-9,9A- DIHYDRO-3H-XANTHEN-9-YL)-BENZOIC ACID | L,P | 2MPA | 0.72 | ![]() |
CYF![]() | 5-[2-(2-AMINO-2-CARBAMOYL-ETHYLSULFANYL)- ACETYLAMINO]-2-(3,6-DIHYDROXY-9,9A- DIHYDRO-3H-XANTHEN-9-YL)-BENZOIC ACID | I,L | 1DZH | 0.72 | ![]() |
NM1![]() | 3-(7-BENZYL-4,5-DIHYDROXY-1,1-DIOXO- 3,6-BIS-PHENOXYMETHYL-1L6-[1,2,7]THIADIAZEPAN- 2-YLMETHYL)-N-METHYL-BENZAMIDE | B | 1G2K | 0.7 | ![]() |
TMS![]() | N-PROPYL-4-[(E)-2-(3,4,5-TRIMETHOXY- PHENYL)-VINYL]-BENZAMIDE | A,B | 1X6W | 0.78 | ![]() |
NOV![]() | NOVOBIOCIN | A,B | 1KIJ | 0.74 | ![]() |
NOV![]() | NOVOBIOCIN | A,B | 1S14 | 0.74 | ![]() |
NOV![]() | NOVOBIOCIN | A | 1AJ6 | 0.74 | ![]() |
INX![]() | 2-(CARBOXYMETHOXY)-5-[(2S)-2-({(2S)- 2-[(3-CARBOXYPROPANOYL)AMINO] - 3-PHENYLPROPANOYL}AMINO)-3-OXO- 3-(PENTYLAMINO)PROPYL]BENZOIC ACID | A | 1G7G | 0.72 | ![]() |
GL8![]() | GALANTHAMINE DERIVATIVE | A | 1W4L | 0.72 | ![]() |
XN2![]() | N-[2-HYDROXY-1-INDANYL]-5-[(2-TERTIARYBUTYLAMINOCARBONYL)- 4(BENZO[1,3]DIOXOL-5-YLMETHYL)- PIPERAZINO]-4-HYDROXY-2-(1-PHENYLETHYL)- PENTANAMIDE | A,B | 1K6V | 0.76 | ![]() |
DM3![]() | 6-DEOXYDAUNOMYCIN | A | 1D14 | 0.72 | ![]() |
DM2![]() | DOXORUBICIN | A | 2DR6 | 0.72 | ![]() |
DM2![]() | DOXORUBICIN | A | 1P20 | 0.72 | ![]() |
DM2![]() | DOXORUBICIN | A | 1I1E | 0.72 | ![]() |
DM2![]() | DOXORUBICIN | A | 151D | 0.72 | ![]() |
DM2![]() | DOXORUBICIN | A | 1D12 | 0.72 | ![]() |
DM2![]() | DOXORUBICIN | A | 1DA9 | 0.72 | ![]() |
561![]() | 6-HYDROXY-3-{(4R)-1-[4-(1-NAPHTHYLAMINO)- 4-OXOBUTYL]-1,2,3-TRIAZOLIDIN-4- YL}-1-BENZOFURAN-5-CARBOXYLIC ACID | A,B | 2QCT | 0.73 | ![]() |
DM6![]() | 4'-EPIDOXORUBICIN | A | 1D15 | 0.72 | ![]() |
DM6![]() | 4'-EPIDOXORUBICIN | A | 1D54 | 0.72 | ![]() |
DM6![]() | 4'-EPIDOXORUBICIN | A | 1D58 | 0.72 | ![]() |
DM6![]() | 4'-EPIDOXORUBICIN | A | 1QDA | 0.72 | ![]() |
AB8![]() | (1S,3R,8AS)-8-(2-{(4S,6S)-3-(4- HYDROXY-3-METHOXYBENZYL)-4-[2-(METHYLAMINO)- 2-OXOETHYL]-2-OXO-1,3-OXAZINAN- 6-YL}ETHYL)-3,7-DIMETHYL-1,2,3,7,8,8A- HEXAHYDRONAPHTHALEN-1-YL (2R)-2- METHYLBUTANOATE | A,B | 1XDG | 0.76 | ![]() |
BD2![]() | 3-[(4-HYDROXYBENZOYL)AMINO]AZEPAN- 4-YL 4-(2-HYDROXYBENZOYL)BENZOATE | A | 1RE8 | 0.71 | ![]() |
S44![]() | (2S)-2-(4-propoxy-3-{[({4-[(3S,5S,7S)- tricyclo[3.3.1.1~3,7~]dec-1-yl]phenyl}carbonyl)amino]methyl}benzyl)butanoic acid | A | 2ZNN | 0.72 | ![]() |
S44![]() | (2S)-2-(4-propoxy-3-{[({4-[(3S,5S,7S)- tricyclo[3.3.1.1~3,7~]dec-1-yl]phenyl}carbonyl)amino]methyl}benzyl)butanoic acid | A,B | 2ZNO | 0.72 | ![]() |
XN3![]() | N-[2(R)-HYDROXY-1(S)-INDANYL]-5- [(2(S)-TERTIARY BUTYLAMINOCARBONYL)- 4(BENZO[1,3]DIOXOL-5-YLMETHYL)- PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE | A,B | 1K6P | 0.76 | ![]() |
EH5![]() | N-(1-BENZYL-3-{[3-(1,3-DIOXO-1,3- DIHYDRO-ISOINDOL-2-YL)-PROPIONYL]- [2-(HEXAHYDRO-BENZO[1,3]DIOXOL- 5-YL)-ETHYL]-AMINO}-2-HYDROXY-PROPYL)- 4-BENZYLOXY-3,5-DIMETHOXY-BENZAMIDE | A | 1LF3 | 0.85 | ![]() |
BMY![]() | BALHIMYCIN | A,B,C,D,E,F, G,H,I,J,K,L, M,N,O,P,S | 1GO6 | 0.73 | ![]() |
BMY![]() | BALHIMYCIN | A,B,C,D,E,M | 1HHU | 0.73 | ![]() |
DM1![]() | DAUNOMYCIN | A | 152D | 0.72 | ![]() |
DM1![]() | DAUNOMYCIN | A,B,C,D | 1O0K | 0.72 | ![]() |
DM1![]() | DAUNOMYCIN | A | 1JO2 | 0.72 | ![]() |
DM1![]() | DAUNOMYCIN | A,B | 308D | 0.72 | ![]() |
DM1![]() | DAUNOMYCIN | A | 1D33 | 0.72 | ![]() |
DM1![]() | DAUNOMYCIN | A | 110D | 0.72 | ![]() |
DM1![]() | DAUNOMYCIN | A | 1D11 | 0.72 | ![]() |
DM1![]() | DAUNOMYCIN | A | 427D | 0.72 | ![]() |
DM1![]() | DAUNOMYCIN | A | 2D34 | 0.72 | ![]() |
DM1![]() | DAUNOMYCIN | A | 3F8F | 0.72 | ![]() |
DM1![]() | DAUNOMYCIN | A | 1D10 | 0.72 | ![]() |
DM1![]() | DAUNOMYCIN | A | 1DA0 | 0.72 | ![]() |
DM4![]() | 1-O-DEMETHYL-6-DEOXYDOXORUBICIN | A | 1D37 | 0.71 | ![]() |
GUM![]() | 4-METHYL-UMBELLIFERYL-N-ACETYL- CHITOBIOSE | A | 1BB7 | 0.72 | ![]() |
GGO![]() | (4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL- 5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN- 2-ONE | B | 2OQI | 0.72 | ![]() |
941![]() | 2-(4-{2-TERT-BUTOXYCARBONYLAMINO- 2-[4-(3-HYDROXY-2-METHOXYCARBONYL- PHENOXY)-BUTYLCARBAMOYL]-ETHYL}- PHENOXY)-MALONIC ACID | A | 1PYN | 0.72 | ![]() |